Aims/hypothesis Pantothenate kinase (PANK) is the first enzyme in CoA biosynthesis. Pank1-deficient mice have 40% lower liver CoA and fasting hypoglycaemia, which results from reduced gluconeogenesis. Single-nucleotide polymorphisms in the human PANK1 gene are associated with insulin levels, suggesting a link between CoA and insulin homeostasis. We determined whether Pank1 deficiency (1) modified insulin levels, (2) ameliorated hyperglycaemia and hyperinsulinaemia, and (3) improved acute glucose and insulin tolerance of leptin (Lep)-deficient mice. Methods Serum insulin and responses to glucose and insulin tolerance tests were determined in Pank1-deficient mice. Levels of CoA and regulating enzymes were measured in liver and skeletal muscle of Lep-deficient mice. Double Pank1/ Lep-deficient mice were analysed for the diabetes-related phenotype and global metabolism. Results Pank1-deficient mice had lower serum insulin and improved glucose tolerance and insulin sensitivity compared with wild-type mice. Hepatic and muscle CoA was abnormally high in Lep-deficient mice. Pank1 deletion reduced hepatic CoA but not muscle CoA, reduced serum glucose and insulin, but did not normalise body weight or improve acute glucose tolerance or protein kinase B phosphorylation in Lep-deficient animals. Pank1/Lep double-deficient mice exhibited reduced whole-body metabolism of fatty acids and amino acids and had a greater reliance on carbohydrate use for energy production.
Introduction
Elevated gluconeogenesis is central to hyperglycaemia in type 2 diabetes [1] , and suppression of this pathway by the widely used drug, metformin, is effective in reducing blood glucose [2] . Gluconeogenesis and fatty acid oxidation during fasting are inter-related [3] , and the CoA supply in the liver was recently identified as a mediator of the two processes [4] .
CoA is an essential cofactor required for the metabolism of carbohydrates, amino acids, fatty acids and ketone bodies for energy production, and for multiple synthetic processes, including sterol, bile acid, fatty acid and complex lipid biosynthesis [5] . Tissue CoA levels are tightly regulated and adjust to the metabolic state by a balance between synthesis and degradation. Nudix hydrolase 7 (NUDT7) degrades shortchain acyl-CoAs [6] , and is negatively regulated by peroxisome proliferator-activated receptor α [7] . CoA synthesis starts with phosphorylation of pantothenic acid (vitamin B 5 ) by pantothenate kinase (PANK). Four mammalian PANK isoforms encoded by three genes [8] regulate CoA biosynthesis through differential isoform expression in tissues [4, 9, 10] , differential sensitivity to feedback inhibition by acyl-CoAs [8, [11] [12] [13] , selective activation by metabolites [11, 14] and subcellular localisation [12, 15] . Although the PANK enzymes are located in the cytosol, nucleus or mitochondria [15] , the latter steps in CoA synthesis occur in the cytosol [16] and CoA is transported into mitochondria [17] [18] [19] for use in oxidative reactions. The Pank1 gene encodes PANK1α and PANK1β, the PANK isoforms least sensitive to feedback regulation by acetyl-CoA [5, 13] , and is required for the hepatic CoA increase during the switch from glucose to fatty acid oxidation that occurs in the fasted state [4] . Liver and kidney express PANK1β in highest abundance and are characterised by the highest CoA levels [13, 20] . PANK2 and PANK3 are abundant isoforms in brain [12] , and a human neurodegenerative disease is associated with mutations in the PANK2 gene [21] .
Fatty acid oxidation relies heavily on the availability of free CoA to produce acetyl-CoA from long-chain acyl-CoA breakdown. Acetyl-CoA, in turn, is an activator of pyruvate carboxylase, the first enzyme in gluconeogenesis. Acyl-CoA catabolism additionally produces NADH and is linked to ATP production, both of which are required for gluconeogenesis. Reduction of hepatic CoA due to Pank1 deficiency [4] or chemical inhibition of all the PANK isoforms [20] results in reduced fatty acid oxidation and hypoglycaemia, thus demonstrating that modulation of CoA has a direct impact on glucose production. In particular, Pank1-deficient mice are unable to convert pyruvate, oxaloacetate or glycerol into glucose [4] , although transcription of key enzymes increases as expected in the fasted state to support gluconeogenesis. Thus, PANK1 may be a suitable target for intervention in disorders with deregulated gluconeogenesis and hyperglycaemia such as type 2 diabetes.
An association between polymorphisms in the PANK1 gene and insulin levels was recently uncovered in a birth cohort from the most genetically isolated regions of Finland [22] . We tested the hypothesis that reduction of CoA levels by global deletion of Pank1 could mitigate the hyperglycaemia and hyperinsulinaemia of diabetic mice. We used the ob/ob mouse, an established model, to investigate the metabolic disturbances leading to type 2 diabetes [23] . The ob/ob mouse is leptin-deficient (Lep −/− ) [24] and characterised by obesity, hyperglycaemia, hyperinsulinaemia and insulin resistance [25] . We generated Lep −/− mice that were deficient in Pank1 expression and compared their diabetic phenotype and wholebody metabolism with those of the Lep −/− mice. fasted for 24 h. AUCs for individual mice were reported as the mean ± SEM and were calculated using initial blood glucose as baseline. For ITTs, individual glucose curves were expressed as percentage of the initial blood glucose, and AUC was calculated using y=0 as baseline.
Methods

Animals
Tissue measurements Tissues were frozen in liquid nitrogen and stored at −80°C. Glycogen [26] was quantified with a Biovision assay kit. Liver triacylglycerol and cholesterol were quantified using an Iatroscan (Shell-usa, Spotsylvania, VA, USA). CoA levels were determined as described previously [12, 27, 28] . DNA was quantified as described [29] . Glycogen, triacylglycerol, cholesterol and CoA were normalised to DNA. Carnitines were determined as described [4] . Transcripts were quantified by real-time quantitative RT-PCR with primers as described [4, 9] and as follows: Carnitine palmitoyltransferase 1α (Cpt1α) Cpt1α-forward ACGCAT GACAGCACTGGCCC, Cpt1α-reverse CCTCCCCAGG GATGCGGGAA; long-chain acyl-CoA dehydrogenase (Acadl) Acadl-forward CTTGCTTGGCATCAACATCGCA GA, Acadl-reverse ATTGGAGTACGCTTGCTCTTCCCA.
Enzyme activities Hepatic PANK activity and fatty acid oxidation were measured as described [4, 30] . [
14 C]Palmitic acid oxidation was calculated from the slope of three time points, peroxisome oxidation was determined after a 5 min preincubation with 50 μmol/l antimycin A and 10 μmol/l rotenone, and mitochondrial oxidation was calculated as the difference with and without inhibitors.
14 C-labelled acidsoluble metabolites were assessed by scintillation counting. Hepatocyte isolation Hepatocytes were isolated from overnight fasted mice and suspended at (0.8-1)×10
6 cells/ml in buffer without glucose [31] , with or without 2 mmol/l pyruvate or 2 mmol/l pyruvate plus 20 mmol/l lactate. Suspensions were incubated at 37°C with moderate shaking for 2 h with >90% viability. Hepatocytes were centrifuged at 1,000 g for 6 min, and glucose in the supernatant fraction was quantified using an assay kit (Sigma-Aldrich, St Louis, MO, USA).
Immunoblotting The antibody against full-length mouse NUDT7 was raised in rabbit, and used at 1:10,000 dilution. The β-actin antibody (Sigma-Aldrich) was used at 1:5,000 dilution. The glyceraldehyde-3-phosphate dehydrogenase antibody (Abcam, Cambridge, MA, USA) was used at 1:3,000 dilution. The protein kinase B (AKT) and phospho-AKT antibodies (Cell Signaling Technology, Danvers, MA, USA) were used at 1:1,000 dilution.
Statistical analysis Statistical significance was calculated by unpaired two-tailed Student's t test using GraphPad Prism 5 (GraphPad Software, La Jolla, CA, USA).
Results
Reduced serum insulin and improved insulin tolerance in Pank1
−/− mice Insulin was 50% lower in fasted Pank1
−/− mice (36±7 pmol/l, n=11) compared with wild-type mice (72±10 pmol/l, n=13, p=0.007). The Pank1 −/− mice cleared a glucose bolus faster than wild-type controls (Fig. 1a, b ) while maintaining insulin levels that were similar to wildtype mice for up to 30 min after glucose injection (mean value of 86 pmol/l, n=4-8 per genotype), consistent with improved glucose uptake. The mice additionally exhibited improved insulin tolerance (Fig. 1c, d ). These data indicate a relationship between PANK1 and insulin homeostasis in mice, consistent with results of a human genome-wide association study [22] .
Deregulated hepatic CoA levels in Lep −/− mice Hepatic CoA content was about twofold higher in fed leptin-deficient animals than non-obese littermates, whereas fasted CoA was equivalent (Fig. 2a) . These observations were similar to those reported previously for db/db mice [32] . Pank transcript expression was not significantly different between genotypes (Fig. 2b ), but PANK activity, representing the total amount of PANK protein, was about 30% higher ( ; n=3/genotype; p=0.009). The modestly higher PANK activity in the Lep −/− liver may be due to alteration of either protein stability or post-translational modification of any of the four PANK isoforms. Nudt7 transcripts were downregulated 10-fold (Fig. 2b) , and NUDT7 protein was also reduced in Lep −/− mice (Fig. 2d) . Fasting CoA levels increased as expected in the controls but were unchanged in the Lep −/− mice (Fig. 2a) . The elevated CoA in fed Lep −/− mice correlated with higher PANK activity and reduced Nudt7 expression, mice in both the fed and fasted states, where mitochondrial β-oxidation was selectively affected (Fig. 3b) . The liver carnitine profiles confirmed that Pank1 deficiency resulted in chronically reduced fatty acid oxidation in Lep −/− mice, as unmetabolised fatty acids were off-loaded from acyl-CoAs to acylcarnitines. Free carnitine was not limiting in livers from Pank1 −/− Lep −/− mice (Fig 3c) , and significant accumulation of long-chain acylcarnitines in the fed (C14, C18) and fasted state (C16, C16:1, C18, C18:1, C18:2) was consistent with a partial block and reduced rate of fatty acid oxidation (Fig. 3e) . On the other hand, the mRNAs for carnitine palmitoyltransferase α (Cpt1a), long-chain acyl-CoA dehydrogenase (Acadl) and peroxisome proliferator-activated receptor α (Pparg1a) were the same between genotypes ( Table 2 ), indicating that the transcriptional programme for fatty acid breakdown and use was intact.
Pank1 deficiency led to a dramatic reduction in gluconeogenic capacity without altering the transcription of the key enzymes, phosphoenolpyruvate carboxykinase 1 (Pck1) and glucose-6-phosphatase (G6pc) ( Table 2) . Glucose production was substantially reduced after an acute challenge with the amino acid alanine (Fig. 4a, b) , a gluconeogenic precursor used by the liver almost exclusively [33] . Glucose production from hepatocytes isolated from Pank1 −/− Lep −/− mice was also dramatically reduced compared with hepatocytes from Pank1 +/+ Lep −/− mice (Fig. 4c) . Altogether, these data indicate that the CoA supply for fatty acid oxidation became limiting after deletion of Pank1 in Lep −/− mice, which, in turn, reduced glucose production from hepatocytes. (Fig. 5a, b) . However, Pank1 deficiency resulted in dramatically reduced blood (Table 3 ). These data indicate that the chronic hyperglycaemia and hyperinsulinaemia associated with the type 2 diabetic state were significantly improved despite chronic obesity. Muscle glycogen stores were significantly depleted in fasted Pank1 −/− Lep −/− mice, and a trend towards lower hepatic glycogen was evident (Table 3) , suggesting enhanced glucose use. However, unlike the Pank1 −/− mice, the Pank1 −/− Lep −/− mice did not exhibit an improved response to a glucose bolus (Fig. 5c, d ). The acute response of Pank1 −/− Lep −/− mice to insulin was only slightly improved at best (Fig. 5e, f ) , and examination of AKT Data are mean ± SEM for 4-6 fed mice per group mice, similarly to fasted levels in wild-type animals ( Fig. 6b) , indicating deregulation of CoA metabolism. In contrast with the results in liver, however, PANK1 deficiency did not reduce either fed or fasting CoA levels in muscles from Lep −/− mice.
The muscle acyl-CoA levels in Lep −/− mice were elevated compared with wild-type mice, but were not reduced after Pank1 deletion (ESM Fig. 2) . Investigation of the Pank transcript distribution in skeletal muscle showed that Pank1b expression was 100-fold lower (p<0.001) and Pank1a expression was 50% lower in Lep −/− muscle than liver ( (Fig. 7a) , and this correlated with the significantly reduced hyperglycaemia in fed Pank1 −/− Lep −/− animals ( Table 3 ). The calculated energy expenditure did not indicate a significant difference between genotypes (Fig. 7b) , although the metabolic rate, as measured by oxygen consumption, tended to be lower in the Pank1 Lep −/− mice without attaining statistical significance (data not shown). Serum acylcarnitines were measured as an indication of global fatty acid and amino acid metabolism. In the fed state, P a n k 1 − / − L e p − / − m i c e h a d i n c r e a s e d b u t y r y l / isobutyrylcarnitine (C4) and palmitoylcarnitine (C16), while oleoylcarnitine (C18:1) was reduced compared with Pank1 (Fig. 7e, f ) . After an overnight fast, Pank1
Lep −/− mice exhibited a modest increase in serum myristoylcarnitine (C14) (Fig. 7f ) , while the branched-chain a m i n o a c i d -d e r i v e d p r o p y l c a r n i t i n e ( C 3 ) a n d α-methylbutyryl/isovalerylcarnitine (C5) were reduced threefold and twofold, respectively (Fig. 7e) . Consistent with the carnitine profiling, valine was significantly decreased in Pank1 −/− Lep −/− mice, and both isoleucine and leucine tended to be lower (Fig. 7c) . Not all serum amino acids were decreased in the Pank1 −/− Lep −/− mice, however. Both methionine and serine were modestly increased, while alanine was twice as high in Pank1 −/− Lep −/− mice as in controls (Fig. 7c) .
Other metabolites that increased in the serum of fasted Pank1 −/− Lep −/− mice were β-hydroxybutyrate and NEFAs, while cholesterol was reduced compared with Pank1 +/+ Lep −/− mice ( Table 3 ). The elevated alanine in the Pank1 −/− Lep −/− mice correlated with reduced alanine consumption by liver (Fig. 4) . Altogether, these data indicate that deletion of Pank1 altered not only fatty acid but also amino acid metabolism, and increased glucose use. 
Discussion
A key finding of this investigation is that deregulated CoA metabolism in both liver and skeletal muscle probably contributes to the diabetic phenotype of the leptin-deficient mice.
The chronic aspects of the phenotype-hyperglycaemia and hyperinsulinaemia-were corrected by limiting CoA synthesis in liver, but the acute responses to high glucose and high insulin were unresolved. The data suggest that the resolution of the hyperinsulinaemia was an adaptive response to lower serum glucose levels. Body weight, food intake and hepatic triacylglycerol content were unchanged after deletion of Pank1 in Lep −/− mice, as were the amounts of acyl-CoA intermediates in liver and muscle. These results suggest that [9, 34] or, in the latter case, enhanced adipose tissue lipolysis. Reduced tissue glycogen content and higher RER indicated increased glucose use in the periphery. Elevated alanine levels in blood correlated with reduced use of alanine for gluconeogenesis, although reduced branched-chain amino acid levels in fasted Pank1 −/− Lep −/− mice (Fig. 6b) suggested that accumulation of serum alanine could also have been derived from increased synthesis of this amino acid in the muscle. Alanine production entails transfer of an amino group to pyruvate, and the process is tightly coupled to branchedchain amino acid degradation [35] . Thus, higher glucose use in the Pank1 −/− Lep −/− mice could provide more pyruvate for alanine synthesis at the expense of the branched-chain amino acids. Interestingly, branched-chain amino acids, C3/C5 acylcarnitines and alanine are components of a metabolite cluster that is strongly associated with, and elevated under, conditions of insulin resistance [36, 37] . Although branchedchain amino acids and C3/C5 acylcarnitines were reduced, serum alanine was higher in the Pank1 −/− Lep −/− mice, and this correlated with unimproved systemic insulin resistance. The beneficial physiological effect of CoA limitation was not dependent on changes in the transcription of regulatory enzymes in the fatty acid oxidation or gluconeogenic pathways, but rather resulted from a reduced rate of hepatic fatty acid oxidation due to limitation of substrate supply. The inability of Lep −/− mice to modulate hepatic CoA represents one molecular aspect of metabolic inflexibility that correlates with failure to suppress hepatic glucose production [38] . Repression of Nudt7 expression is reported to follow activation of peroxisome proliferator-activated receptor α [7] , which would be expected to be engaged in fatty liver. However, the mechanisms underlying the CoA deregulation in Lep −/− mice are not known and will be the subject of future investigation.
